Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Oct-24 4:15 PM View:  | Roemer Alan S. Director | In8bio, Inc. (INAB) | 04-Oct-24 | Grant | 126,582 | -- | -- | 80% 158.45K to 285.03K | |
| 08-Oct-24 4:15 PM View: | Ho William Tai-Wei President and CEO Director 10% Owner | In8bio, Inc. (INAB) | 04-Oct-24 | Grant | 126,582 | -- | -- | 5% 2.53M to 2.66M | |
| 08-Oct-24 4:15 PM View: | McCall Patrick Chief Financial Officer | In8bio, Inc. (INAB) | 04-Oct-24 | Grant | 25,316 | -- | -- | 95% 26.75K to 52.07K | |
| 08-Oct-24 4:15 PM View: | Rochlin Kate Chief Operating Officer | In8bio, Inc. (INAB) | 04-Oct-24 | Grant | 25,316 | -- | -- | 144% 17.56K to 42.87K | |
| 08-Oct-24 4:15 PM View: | Brandt Peter C. Director | In8bio, Inc. (INAB) | 04-Oct-24 | Grant | 253,164 | -- | -- | 68% 369.73K to 622.89K | |
| 15-Dec-23 8:23 AM View: | McCall Patrick Chief Financial Officer | In8bio, Inc. (INAB) | 13-Dec-23 | Grant | 20,492 | -- | -- | 327% 6.26K to 26.75K | |
| 15-Dec-23 8:26 AM View: | Epperly Corinne Director | In8bio, Inc. (INAB) | 13-Dec-23 | Grant | 81,967 | -- | -- | 100% 0 to 81.97K | |
| 15-Dec-23 8:19 AM View: | Lamb Lawrence EVP and CSO | In8bio, Inc. (INAB) | 13-Dec-23 | Grant | 1,639 | -- | -- | 2% 99.73K to 101.37K | |
| 15-Dec-23 8:22 AM View: | Rochlin Kate Chief Operating Officer | In8bio, Inc. (INAB) | 13-Dec-23 | Grant | 12,295 | -- | -- | 234% 5.26K to 17.56K | |
| 15-Dec-23 8:18 AM View: | Brandt Peter C. Director | In8bio, Inc. (INAB) | 13-Dec-23 | Grant | 81,967 | -- | -- | 28% 287.76K to 369.73K | |
| 15-Dec-23 8:25 AM View: | Roemer Alan S. Director | In8bio, Inc. (INAB) | 13-Dec-23 | Grant | 102,459 | -- | -- | 183% 55.99K to 158.45K | |
| 15-Dec-23 8:24 AM View: | Ho William Tai-Wei President and CEO Director 10% Owner | In8bio, Inc. (INAB) | 13-Dec-23 | Grant | 81,967 | -- | -- | 3% 2.45M to 2.53M | |
| 15-Dec-23 8:27 AM View: | Graff Jeremy R. Director | In8bio, Inc. (INAB) | 13-Dec-23 | Grant | 2,049 | -- | -- | 82% 2.5K to 4.55K | |
| 15-Dec-23 8:20 AM View: | Goswami Trishna Chief Medical Officer | In8bio, Inc. (INAB) | 13-Dec-23 | Grant | 4,098 | -- | -- | 156% 2.63K to 6.73K | |
| 15-Sep-23 4:51 PM View: | Graff Jeremy R. Director | In8bio, Inc. (INAB) | 13-Sep-23 | Private Purchase | 2,500 | $0.95 | $2,375.00 | 100% 0 to 2.5K | |
| 28-Aug-23 4:43 PM View: | McCall Patrick Chief Financial Officer | In8bio, Inc. (INAB) | 25-Aug-23 | Private Purchase | 1,000 | $1.03 | $1,030.00 | 19% 5.26K to 6.26K | |
| 28-Aug-23 4:42 PM View: | Ho William Tai-Wei President and CEO Director 10% Owner | In8bio, Inc. (INAB) | 24-Aug-23 | Private Purchase | 23,800 | $1.05 | $24,990.00 | < 1% 2.43M to 2.45M | |
| 01-Aug-23 4:41 PM View: | Fairbairn Emily Director | In8bio, Inc. (INAB) | 28-Jul-23 | Disposition (other) | 4,111,960 | -- | -- | (97%) 4.23M to 119.04K | |
| 13-Dec-22 7:01 AM View: | Kreis Leslie W. Director 10% Owner | In8bio, Inc. (INAB) | 12-Dec-22 | Private Purchase Duplicate | 75,001 | $2.48 | $185,912.00 | < 1% 8.52M to 8.6M | |
| 13-Dec-22 7:00 AM View: | Fletcher Aaron G.L. Director 10% Owner | In8bio, Inc. (INAB) | 12-Dec-22 | Private Purchase | 75,001 | $2.48 | $185,912.00 | < 1% 8.52M to 8.6M | |
| 29-Sep-22 6:14 AM View: | Fletcher Aaron G.L. Director 10% Owner | In8bio, Inc. (INAB) | 28-Sep-22 | Private Purchase Duplicate | 25,000 | $2.02 | $50,535.00 | < 1% 8.5M to 8.53M | |
| 29-Sep-22 6:08 AM View: | Kreis Leslie W. Director 10% Owner | In8bio, Inc. (INAB) | 28-Sep-22 | Private Purchase | 25,000 | $2.02 | $50,535.00 | < 1% 8.5M to 8.53M | |
| 30-Aug-22 1:16 PM View: | Fletcher Aaron G.L. Director 10% Owner | In8bio, Inc. (INAB) | 29-Aug-22 | Purchase Duplicate | 40,000 | $2.02 | $80,800.00 | < 1% 8.46M to 8.5M | |
| 30-Aug-22 8:10 AM View: | Kreis Leslie W. Director 10% Owner | In8bio, Inc. (INAB) | 29-Aug-22 | Purchase | 40,000 | $2.02 | $80,800.00 | < 1% 8.46M to 8.5M | |
| 30-Aug-22 1:16 PM View: | Fletcher Aaron G.L. Director 10% Owner | In8bio, Inc. (INAB) | 26-Aug-22 | Private Purchase Duplicate | 11,214 | $2.01 | $22,540.10 | < 1% 8.45M to 8.46M | |
| 30-Aug-22 8:10 AM View: | Kreis Leslie W. Director 10% Owner | In8bio, Inc. (INAB) | 26-Aug-22 | Private Purchase | 11,214 | $2.01 | $22,540.10 | < 1% 8.45M to 8.46M | |
| 18-Aug-22 7:16 PM View: | Fletcher Aaron G.L. Director 10% Owner | In8bio, Inc. (INAB) | 17-Aug-22 | Private Purchase | 50,000 | $1.93 | $96,500.00 | < 1% 8.4M to 8.45M | |
| 18-Aug-22 8:00 PM View: | Kreis Leslie W. Director 10% Owner | In8bio, Inc. (INAB) | 17-Aug-22 | Private Purchase Duplicate | 50,000 | $1.93 | $96,500.00 | < 1% 8.4M to 8.45M | |
| 18-Aug-22 4:15 PM View: | Ho William Tai-Wei President, CEO and CFO Director | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 26,315 | $1.90 | $49,998.50 | 1% 2.4M to 2.43M | |
| 18-Aug-22 4:10 PM View: | Lamb Lawrence EVP and CSO | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 526 | $1.90 | $999.40 | < 1% 99.2K to 99.73K | |
| 18-Aug-22 4:14 PM View: | Rochlin Kate Chief Operating Officer | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 5,263 | $1.90 | $9,999.70 | 100% 0 to 5.26K | |
| 18-Aug-22 4:07 PM View: | Brandt Peter C. Director | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 105,263 | $1.90 | $200,000.00 | 58% 182.5K to 287.76K | |
| 17-Aug-22 10:25 AM View: | Fletcher Aaron G.L. Director 10% Owner | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 1,773,680 | $1.90 | $3,370,000.00 | 28% 6.37M to 8.14M | |
| 17-Aug-22 10:27 AM View: | Kreis Leslie W. Director 10% Owner | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase Duplicate | 1,773,680 | $1.90 | $3,370,000.00 | 28% 6.37M to 8.14M | |
| 18-Aug-22 4:08 PM View: | Roemer Alan S. Director | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 26,315 | $1.90 | $49,998.50 | 89% 29.67K to 55.99K | |
| 18-Aug-22 4:17 PM View: | Fairbairn Emily Director 10% Owner | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 789,473 | $1.90 | $1,500,000.00 | 23% 3.44M to 4.23M | |
| 18-Aug-22 4:13 PM View: | McCall Patrick Chief Financial Officer | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 5,263 | $1.90 | $9,999.70 | 100% 0 to 5.26K | |
| 18-Aug-22 4:11 PM View: | Goswami Trishna Chief Medical Officer | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 2,631 | $1.90 | $4,998.90 | 100% 0 to 2.63K | |
| 18-Aug-22 4:09 PM View: | Greenwood Luba Director | In8bio, Inc. (INAB) | 16-Aug-22 | Private Purchase | 526 | $1.90 | $999.40 | 7% 7.3K to 7.83K | |
| 09-May-22 4:25 PM View: | Lamb Lawrence EVP and CSO | In8bio, Inc. (INAB) | 05-May-22 | Option Exercise | 26,204 | $1.07 | $27,999.00 | 36% 73.0K to 99.2K | |
| 03-Aug-21 10:00 PM View: | Kreis Leslie W. 10% Owner | In8bio, Inc. (INAB) | 03-Aug-21 | Conversion Duplicate | 6,625,100 | -- | -- | 100% 0 to 6.63M | |
| 03-Aug-21 10:00 PM View: | Fletcher Aaron G.L. 10% Owner | In8bio, Inc. (INAB) | 03-Aug-21 | Conversion | 6,625,100 | -- | -- | 100% 0 to 6.63M |
